Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis (START)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Leiden University Medical Center
Sponsor:
Collaborator:
Netherlands Heart Foundation
Information provided by (Responsible Party):
Willem M. Lijfering, Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT01613794
First received: May 31, 2012
Last updated: March 2, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):